Mobile

Pilot phase IV, multicenter, randomized, open-label and controlled study to assess the evolution of peripheral body fat distribution after switching from AZT containing backbone to Truvada in HIV-1-in...

Update Il y a 4 ans
Reference: EUCTR2005-005786-11

Pilot phase IV, multicenter, randomized, open-label and controlled study to assess the evolution of peripheral body fat distribution after switching from AZT containing backbone to Truvada in HIV-1-infected patients on HAART (RECOMB Study)

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To explore changes in limb fat assessed by DEXA measurements, after the substitution of the Zidovudine + Lamivudine NRTI-backbone by Truvada (TDF+FTC) versus maintaining the original Zidovudine-containing regimen without any change, through 48 wk.

Inclusion criteria

  • Human Immunodeficiency Virus (HIV-1) Infection

Links